Kenvue stock soars as Kimberly-Clark agrees to acquire the consumer health giant. Jim Cramer is positive on KVUE shares ...

Kenvue stock has struggled this year, but an acquisition offer is giving investors hope leading up to this week's earnings ...

Kimberly-Clark is buying Tylenol maker Kenvue for nearly $50 billion. Wall Street isn’t too fond of the deal—for good reason.

As a Kenvue Inc. ( KVUE) shareholder, the core question is whether the proposed acquisition by Kimberly-Clark Corporation ( ...

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...

Under the agreement, each Kenvue Inc. (NYSE:KVUE) shareholder would receive $3.5 per share in cash as well as 0.14625 ...

Kimberly-Clark announces the acquisition of Kenvue, the maker of Tylenol, in a landmark $48.7 billion deal to create a ...

A number of prominent hedge funds are likely applauding Monday’s news that Kimberly-Clark Corp. has agreed to acquire Kenvue ...

The purchase of Kenvue by Kimberly-Clark announced Monday would mark the close of a short, rocky term of independence for ...